Written answers
Tuesday, 3 October 2017
Department of Health
Medicinal Products Availability
Billy Kelleher (Cork North Central, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
360. To ask the Minister for Health the status of the drug ocrelizumab for the treatment of multiple sclerosis; if the drug is being assessed by the National Centre for Pharmacoeconomics, NCPE; and if not, if it will be assessed in the near future. [41461/17]
Simon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source
The HSE has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drug schemes, in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for reply to the Deputy.
No comments